| Sun Pharmaceutical Industries Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524715 |
NSE Symbol : SUNPHARMA |
P/E(TTM) : 146.87 |
|
ISIN Demat : INE044A01036 |
Div & Yield% : 0.82 |
EPS(TTM) : 13.27 |
|
Book Value(₹) : 93.24 |
Market Cap(₹Cr) : 467,630.39 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 20,754.64 | 22,977.40 | 20,275.17 | 20,812.14 | 15,585.98 |
| Other Income | 1,776.43 | 634.33 | 553.48 | 329.29 | 1,196.88 |
| Stock Adjustments | 305.83 | 55.14 | -180.32 | 237.93 | 183.18 |
| Total Income | 22,836.90 | 23,666.87 | 20,648.33 | 21,379.36 | 16,966.04 |
| EXPENDITURE : | |||||
| Raw Materials | 5,774.79 | 5,776.32 | 5,423.79 | 6,292.09 | 5,833.57 |
| Power and Fuel Cost | 488.71 | 463.40 | 450.42 | 495.21 | 422.33 |
| Other Manufacturing Expenses | 1,434.36 | 1,319.45 | 1,195.30 | 1,037.32 | 1,064.32 |
| Selling and Administration Expenses | 5,137.65 | 5,554.08 | 4,754.86 | 4,326.42 | 3,514.05 |
| Miscellaneous Expenses | 1,036.41 | 645.47 | 615.66 | 3,257.27 | 2,086.08 |
| Employee Benefit Expenses | 2,911.30 | 2,691.31 | 2,373.95 | 2,156.95 | 2,000.78 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 6,053.68 | 7,216.84 | 5,834.35 | 3,814.10 | 2,044.91 |
| Interest | 947.84 | 953.89 | 784.08 | 472.18 | 388.10 |
| Gross Profit | 5,105.84 | 6,262.95 | 5,050.27 | 3,341.92 | 1,656.81 |
| Depreciation | 1,311.72 | 1,286.74 | 1,600.62 | 1,600.87 | 1,349.95 |
| Profit Before Tax | 3,794.12 | 4,976.21 | 3,449.65 | 1,741.05 | 306.86 |
| Current Tax | 1,436.55 | 908.62 | 546.10 | 752.77 | -553.58 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -265.85 | -160.49 | 45.37 | -702.44 | 960.43 |
| Reported Net Profit | 2,623.42 | 4,228.08 | 2,858.18 | 1,690.72 | -99.99 |
| Extraordinary Items | -321.25 | 10.25 | -193.46 | -2,181.63 | -1,263.25 |
| Adjusted Net Profit | 2,944.67 | 4,217.83 | 3,051.64 | 3,872.35 | 1,163.26 |
| Adjustment below Net Profit | -2.74 | -397.14 | -19.86 | 7.38 | -14.53 |
| Profit/Loss Balance carried down | 12,948.01 | 12,731.04 | 12,790.88 | 13,612.08 | 15,964.55 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | -1,209.60 | 3,613.97 | 2,898.16 | 2,519.30 | 2,237.95 |
| P & L Balance carried down | 16,778.29 | 12,948.01 | 12,731.04 | 12,790.88 | 13,612.08 |
| Dividend | 2,614.27 | 2,414.30 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 1,600.00 | 1,600.00 | 1,350.00 | 1,150.00 | 1,000.00 |
| Dividend Per Share(Rs) | 16.00 | 16.00 | 13.50 | 11.50 | 10.00 |
| Earnings Per Share-Unit Curr | 10.93 | 17.62 | 11.91 | 7.05 | -0.42 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 93.24 | 99.61 | 98.76 | 98.98 | 102.48 |
| Book Value(Adj)-Unit Curr | 93.24 | 99.61 | 98.76 | 98.98 | 102.48 |
